β-Glucan administration to diabetic rats reestablishes redox balance and stimulates cellular pro-survival mechanisms

Journal of Functional Foods

Volumn 5, Issue 1, 2013, Pages 267-278

  Mirjana, Mihailović ^a   Jelena, Arambašić ^a   Aleksandra, Uskoković ^a   Svetlana, Dinić ^a   Nevena, Grdović ^a   Jelena, Marković ^a   Ibrahim, Mujić ^b   Ana, Šijački D ^c   Goran, Poznanović ^a   Melita, Vidaković ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b University of Biha   (Bosnia and Herzegovina)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Glucan; Akt kinase; Antioxidant activities; Diabetes; Pro survival pathways

Indexed keywords

RATTUS;

EID: 84873270707     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2012.10.016     Document Type: Article

References (34)

1. Angeli J.P., Ribeiro L.R., Bellini M.F., Mantovani M.S. Beta-glucan extracted from the medicinal mushroom Agaricus blazei prevents the genotoxic effects of benzopyrene in the human hepatoma cell line HepG2. Archives of Toxicology 2009, 83:81-86.
2. Babincová M., Bačová Z., Machová E., Kogan G. Antioxidant properties of carboxymethyl glucan: Comparative analysis. Journal of Medicinal Food 2002, 5:79-83.
3. Bhatti F., Mankhey R.W., Asico L., Quinn M.T., Welch W.J., Maric C. Mechanisms of antioxidant and pro-oxidant effects of alphalipoic acid in the diabetic and non-diabetic kidney. Kidney International 2005, 67:1371-1380.
4. Brown G.D., Gordon S. Fungal β-glucans and mammalian immunity. Immunity 2003, 19(2003):311-315.
5. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
6. Cariello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 2003, 26:1589-1596.
7. Chung S.S.M., Ho E.C.M., Lam K.S.M., Chung S.K. Contribution of polyol pathway to diabetes-induced oxidative stress. Journal of American Society of Nephrology 2003, 14:233-236.
8. Djordjevic T., Šiler-Marinkovic S., Dimitrijevic-Brankovic S. Antioxidant activity and total phenolic content in some cereals and legumes. International Journal of Food Properties 2011, 14:175-184.
9. Drabkin D., Austin H. Spectrophotometric studies preparations from washed blood cells. Journal of Biological Chemistry 1935, 112(1935):51-55.
10. Drews G., Krippeit-Drews P., Düfer M. Oxidative stress and beta-cell dysfunction. Pflugers Archiv: European Journal of Physiology 2010, 460:703-718.
11. Fernandez-Real J.M., Lopez-Bermejo A., Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion. Clinical Chemistry 2005, 51:1201-1205.
12. Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circulation Research 2010, 107:1058-1070.
13. Hozová B., Kuniak Ĺ., Moravčíková P., Gajdošová A. Determination of water-insoluble β-d-glucan in the whole-grain cereals and pseudocereals. Czech Journal of Food Sciences 2007, 6:316-324.
14. Hsu M.J., Lee S.S., Lin W.W. Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway. Journal of Leukocyte Biology 2002, 72:207-216.
15. Karácsonyi Š., Kuniak Ĺ. Polysaccharides of Pleurotus ostreatus: Isolation and structure of pleuran, an alkali-insoluble fl-d-glucan. Carbohydrate Polymers 1994, 24:107-111.
16. Kogan G., Staško A., Bauerová K., Polovka M., Šoltés L., Brezová V., Navarová J., Mihalová D. Antioxidant properties of yeast (1/3)-β-d-glucan studied by electron paramagnetic resonance spectroscopy and its activity in the adjuvant arthritis. Carbohydrate Polymers 2005, 61:18-28.
17. Kuda T., Toshiki Enomoto T., Yano T. Effects of two storage b-1,3-glucans, laminaran from Eisenia bicyclis and paramylon from Euglena gracilis, on cecal environment and plasma lipid levels in rats. Journal of Functional Foods 2009, 1:399-404.
18. Li S., Sigmon V.K., Babcock S.A., Ren J. Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes. Life Sciences 2007, 80:1051-1056.
19. Lin B.R., Yu C.J., Chen W.C., Lee H.S., Chang H.M., Lee Y.C., Chien C.T., Chen C.F. Green tea extract supplement reduces d-galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signaling. Journal of Biomedical Science 2009, 16:35-49.
20. Lo H.C., Tsai F.A., Wasser S.P., Yang J.G., Huang B.M. Effects of ingested fruiting bodies, submerged culture biomass, and acidic polysaccharide glucuronoxylomannan of Tremella mesenterica Retz: Fr. on glycemic responses in normal and diabetic rats. Life Science 2006, 78:1957-1966.
21. Lo H.C., Wasser S.P. Medicinal mushrooms for glycemic control in diabetes mellitus: History, current status, future perspectives, and unsolved problems (review). International Journal for Medicinal Mushrooms 2011, 13:401-426.
22. 2 induce caspase-3-independent degradation of Akt/protein kinase B. Journal of Biological Chemistry 2002, 277:42943-42952.
23. Mattila P., Könkö K., Eurola M., Pihlava J.M., Astola J., Vahteristo L., Hietaniemi V., Kumpulainen J., Valtonen M., Piironen V. Contents of vitamins, mineral elements and some phenolic compounds in cultivated mushrooms. Journal of Agriculture and Food Chemistry 2001, 49:2343-2348.
24. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
25. Noh N., King G.L. The role of protein kinase C activation in diabetic nephropathy. Kidney International 2007, 72:49-53.
26. Parker K.M., England J.D., DaCosta J., Hess E.L., Goldstein D.E. Improved colorimetric assay for glycosylated hemoglobin. Clinical Chemistry 1981, 27:669-672.
27. Prabhakar P.K., Doble M. A Target based therapeutic approach towards diabetes mellitus sing medicinal plants. Current Diabetes Reviews 2008, 4:291-308.
28. Rahar S., Swami G., Nagpal N., Nagpal M.A., Singh G.S. Preparation, characterization, and biological properties of β-glucans. Journal of Advanced Pharmaceutical Technology and Research 2011, 2:94-103.
29. Robertson P.R. Antioxidant drugs for treating beta-cell oxidative stress in type 2 diabetes: Glucose-centric vs insulin-centric therapy. Discovery Medicine 2010, 9:132-137.
30. Roupas P., Keogh J., Noakes M., Margetts C., Taylor P. The role of edible mushrooms in health: Evaluation of the evidence. Journal of Functional Foods 2012, 4:687-709.
31. Slameňová D., Kováčiková I., Horváthovaá E., Wsólová L., Navarová J. Carboxymethyl chitin-glucan (CM-CG) protects human HepG2 and HeLa cells against oxidative DNA lesions and stimulates DNA repair of lesions induced by alkylating agents. Toxicolology in Vitro 2010, 24:1986-1992.
32. Tsiapali E., Whaley S., Kalbfleisch J., Ensley H.E.I., Browder W., Williams D.L. Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity. Free Radical Biology and Medicine 2001, 30:393-402.
33. Wiernsperger N.F. Oxidative stress as a therapeutic target in diabetes: Revisiting the controversy. Diabetes and Metabolism 2003, 29:579-585.
34. Zekovic D.B., Kwiatkowski S., Vrvic M., Jakovljevic D., Moran C.A. Natural modified (1-3)-b-glucans in health promotion and disease alleviation. Critical Reviews in Biotechnology 2005, 25:205-230.